Nurix Therapeutics, Inc. ($NRIX)
Hansen Gwenn โ Chief Scientific Officer
Shares
1,452
Price
$25.00
Total Value
$36,300.00
Nearby Earnings
Oct 8, 2026
EPS:Est: -0.60
Revenue:Est: $24.35M
Transaction Details
| Insider | Hansen Gwenn |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Oct 15, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Oct 15, 2026 |
| Shares Sold | 1,452 |
| Price per Share | $25.00 |
| Total Value | $36,300.00 |
| Shares Owned After | 117,227 |
| Derivative | No |
| Accession Number | 0001817160-26-000021 |
| Document | View SEC Filing |